Medicare Enrolled

Dr. Jennifer De Niro, M.D.

Glaucoma Specialist (Ophthalmology) Physician · Oakland, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
491 30TH ST STE 201, Oakland, CA 94609
5108362122
In practice since 2010 (15 years)
NPI: 1669782124 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. De Niro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. De Niro? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. De Niro

Dr. Jennifer De Niro is a glaucoma specialist physician in Oakland, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. De Niro performed 2,416 Medicare services across 2,086 unique beneficiaries.

Between the years covered by Open Payments, Dr. De Niro received a total of $5,067 from 29 pharmaceutical and/or device companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in glaucoma specialist (ophthalmology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. De Niro is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 44% volume in CA $5,067 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,416
Medicare services
Top 44% in CA for glaucoma specialist (ophthalmology) physician
2,086
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~161 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
570 $111 $160
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
456 $84 $114
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
203 $57 $81
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
189 $25 $34
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
185 $117 $153
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
172 $33 $46
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
114 $132 $189
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
92 $39 $49
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
90 $78 $110
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
77 $497 $655
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
70 $14 $19
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
43 $39 $51
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
34 $10 $14
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
32 $133 $197
Laser repair to improve eye fluid flow
A laser procedure used to enhance the drainage of fluid within the eye.
31 $191 $244
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
18 $311 $397
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
16 $98 $134
Complex cataract removal with lens implant
A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision.
13 $647 $894
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
11 $31 $47
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.2% high complexity
10.3% medium
86.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,067
Total received (2018-2024)
Avg $724/year across 7 years
Top 30% in CA for glaucoma specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
214
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,067 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,055
2023
$888
2022
$1,156
2021
$537
2020
$390
2019
$617
2018
$424

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alcon Vision LLC
$329
Bausch & Lomb Americas Inc.
$159
ABBVIE INC.
$145
Oyster Point Pharma, Inc.
$116
Harrow Eye, LLC
$87
SUN PHARMACEUTICAL INDUSTRIES INC.
$85
Thea Pharma Inc.
$43
ANI Pharmaceuticals, Inc.
$26
Krystal Biotech Inc
$24
Glaukos Corporation
$24
Sight Sciences, Inc.
$17
Top 3 companies account for 60.0% of 2024 payments
All-time payments by company (2018-2024) ›
Alcon Vision LLC
$722
Allergan Inc.
$522
Novartis Pharmaceuticals Corporation
$410
Mallinckrodt Hospital Products Inc.
$378
Oyster Point Pharma, Inc.
$372
Bausch & Lomb Americas Inc.
$284
Bausch & Lomb, a division of Bausch Health US, LLC
$281
Sun Pharmaceutical Industries Inc.
$272
Aerie Pharmaceuticals, Inc.
$215
ABBVIE INC.
$211
AbbVie Inc.
$209
Allergan, Inc.
$204
GLAUKOS CORPORATION
$154
Sight Sciences, Inc.
$149
Glaukos Corporation
$104
SUN PHARMACEUTICAL INDUSTRIES INC.
$100
Johnson & Johnson Surgical Vision, Inc.
$88
Harrow Eye, LLC
$87
Thea Pharma Inc.
$62
Eyevance Pharmaceuticals LLC
$54
NotalVision
$27
ANI Pharmaceuticals, Inc.
$26
Krystal Biotech Inc
$24
Shire North American Group Inc
$23
Akorn, Inc.
$21
EyePoint Pharmaceuticals US, Inc.
$20
Dompe US, Inc.
$18
Alcon Research LLC
$15
EYEVANCE PHARMACEUTICALS LLC
$14
Top 3 companies account for 32.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · AcrySof · AcrySof IQ PanOptix · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · COMBIGAN · Centurion · Cequa · Clareon · DURYSTA · Flarex · ForeseeHome · HYDRUS Microstent · ISTENT INJECT W · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · MIEBO · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · PROLENSA · PURIFIED CORTROPHIN GEL · RESTASIS · RESTASIS MULTIDOSE · RYZUMVI · Radius · Rhopressa · Rocklatan · SIMBRINZA · Simbrinza · TECNIS IOL · TRAVATAN Z · TYRVAYA · Tecnis IOL · TobraDex ST · VEVYE · VUITY · VYJUVEK · VYZULTA · XEN · XIIDRA · YUTIQ · Zioptan · enVista MX60 IOL · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a glaucoma specialist physician in Oakland?
Compare glaucoma specialist physicians in the Oakland area by procedure volume, costs, and industry payment transparency.
Browse glaucoma specialist physicians nearby

Geographic Context

Glaucoma specialist physicians within 10 mi
7
Per 100K population
0.4
County median income
$126,240
Nearest hospital
ALTA BATES SUMMIT MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. De Niro is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. De Niro experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. De Niro performed 570 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. De Niro receive payments from pharmaceutical companies?
Yes. Dr. De Niro received a total of $5,067 from 29 companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. De Niro's costs compare to other glaucoma specialist physicians in Oakland?
Dr. De Niro's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. De Niro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →